Go Deep
Drugs Made In America Acquisition II Corp.
Drugs Made In America Acquisition II Corp. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,988 | 34.0 | 1.31 | 0.00 | 965.15 |
| Oct 2026 | 20,994 | 33.9 | 1.31 | 0.00 | 964.20 |
| Oct 2026 | 20,396 | 33.9 | 1.31 | 0.00 | 964.76 |
| Oct 2026 | 20,391 | 34.0 | 1.31 | 0.00 | 965.70 |
| Oct 2026 | 20,388 | 34.0 | 1.31 | 0.00 | 963.79 |
| Oct 2026 | 20,388 | 34.0 | 1.31 | 0.00 | 961.84 |
| Oct 2026 | 20,388 | 34.0 | 1.31 | 0.00 | 965.83 |
Drugs Made In America Acquisition II Corp. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | 4,396,456.0 | 4,337,820.0 | 4,330,608.0 | -46,158.0 |
| EPS | 0.1 | 0.1 | — | 0.0 |
Drugs Made In America Acquisition II Corp. Revenue & Profit: Last 1 Year
| Line Item | Dec 2025 |
|---|---|
| Revenue | 0.0 |
| Net Profit | 4,187,050.0 |
| EPS | 0.2 |
Drugs Made In America Acquisition II Corp. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Total Assets | 504,959,837.0 | 138,064.0 |
| Total Liabilities | 17,800,864.0 | 254,783.0 |
| Total Equity | 487,158,973.0 | -116,719.0 |
Owes vs Owns
Drugs Made In America Acquisition II Corp. owed $0.04 for every $1 it owned in Jun 2026, down from $1.85 in Dec 2024.
| Period | Jun 2026 | Dec 2025 | Dec 2024 |
|---|---|---|---|
| Owes vs Owns | 0.04× | 0.04× | 1.85× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Drugs Made In America Acquisition II Corp. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Other assets 100.0%
How it's funded — Dec 2025
Other liabilities 3.5%Shareholders' equity 96.5%
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Assets | ||
| Cash & short-term investments | 0.0 | 0.0 |
| Receivables | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.0 |
| Intangible assets | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 |
| Other assets | 505.0 | 0.1 |
| Liabilities & equity | ||
| Short-term debt | 0.0 | 0.3 |
| Long-term debt | 0.0 | 0.0 |
| Payables | 0.1 | 0.0 |
| Other liabilities | 17.7 | 0.0 |
| Shareholders' equity | 487.2 | -0.1 |
| Net tangible assets | 487.2 | -0.1 |
Drugs Made In America Acquisition II Corp. Cash Flow
| Line Item | Dec 2025 |
|---|---|
| Operating Activities | -1,018,231.0 |
| Investing Activities | -500,000,000.0 |
| Financing Activities | 501,001,419.0 |